Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification and functional analysis of the SARS-COV-2 nucleocapsid protein
Tianyi Gao, Yingdong Gao, Xiangxiang Liu, et al.
BMC Microbiology (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

An Updated Review of Computer‐Aided Drug Design and Its Application to COVID‐19
Arun Bahadur Gurung, M. Ajmal Ali, Joongku Lee, et al.
BioMed Research International (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 165
SARS-CoV-2 Mutations and Their Impact on Diagnostics, Therapeutics and Vaccines
Suresh Thakur, Shalitha Sasi, Sindhu Gopinathan Pillai, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 139
Neutralizing antibodies for the prevention and treatment of COVID-19
Lanying Du, Yang Yang, Xiujuan Zhang
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 10, pp. 2293-2306
Open Access | Times Cited: 119
Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases
Sareh Kakavandi, Iman Zare, Maryam Vaezjalali, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 67
Discovery of DNA aptamers targeting SARS-CoV-2 nucleocapsid protein and protein-binding epitopes for label-free COVID-19 diagnostics
Suttinee Poolsup, Emil Zaripov, Nico Hüttmann, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 31, pp. 731-743
Open Access | Times Cited: 24
Nucleocapsid Antibodies as an Optimal Serological Marker of SARS‐CoV‐2 Infection: A Longitudinal Study at the Thomayer University Hospital
Markéta Ibrahimová, Vladislava Jamriková, Kateřina Pavelková, et al.
Journal of Clinical Laboratory Analysis (2025)
Open Access | Times Cited: 1
SARS-CoV-2 nucleocapsid protein triggers hyperinflammation via protein-protein interaction-mediated intracellular Cl− accumulation in respiratory epithelium
Lei Chen, Wei‐jie Guan, Zhuo-Er Qiu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 30
COVID-19 Therapeutic Potential of Natural Products
Zhaoxuan Low, Rafidah Lani, Vunjia Tiong, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9589-9589
Open Access | Times Cited: 19
COVID-19 Variants and Vaccine Development
Ziyao Zhao, Sahra Bashiri, Zyta M. Ziora, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 757-757
Open Access | Times Cited: 6
Production and Characterization of Nucleocapsid and RBD Cocktail Antigens of SARS-CoV-2 in Nicotiana benthamiana Plant as a Vaccine Candidate against COVID-19
Tarlan Mamedov, Damla Yuksel, Merve Ilgın, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1337-1337
Open Access | Times Cited: 33
Inhibition of SARS-CoV-2 replication by a ssDNA aptamer targeting the nucleocapsid protein
Yanping Huang, Congcong Huang, Junkai Chen, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 5
Dimerization of SARS-CoV-2 nucleocapsid protein affects sensitivity of ELISA based diagnostics of COVID-19
Wajihul Hasan Khan, Nida Khan, Avinash Mishra, et al.
International Journal of Biological Macromolecules (2022) Vol. 200, pp. 428-437
Open Access | Times Cited: 22
Treatment with quercetin inhibits SARS-CoV-2 N protein-induced acute kidney injury by blocking Smad3-dependent G1 cell-cycle arrest
Wenjing Wu, Wenbiao Wang, Liying Liang, et al.
Molecular Therapy (2022) Vol. 31, Iss. 2, pp. 344-361
Open Access | Times Cited: 22
Transcription Kinetics in the Coronavirus Life Cycle
Katarzyna Grelewska‐Nowotko, Ahmed Eısa Elhag, Tomasz W. Turowski
Wiley Interdisciplinary Reviews - RNA (2025) Vol. 16, Iss. 1
Open Access
Plant-Based Antigen Production Strategy for SARS-CoV-2 Nucleoprotein and RBD and Its Application for Detection of Antibody Responses in COVID-19 Patients
Katerina Takova, Valeria Tonova, Ivan Minkov, et al.
Applied Sciences (2025) Vol. 15, Iss. 2, pp. 786-786
Open Access
Computational Elucidation of Hub Genes and Pathways Correlated with the Development of 5-Fluorouracil Resistance in HCT 116 Colorectal Carcinoma Cell Line
Chun Hoe Tan, Siew‐Huah Lim, Kae Shin Sim
Biochemical Genetics (2025)
Open Access
Longitudinal multi-omics analysis of convalescent individuals with respiratory sequelae 6–36 months after COVID-19
Huqin Yang, Lujia Guan, Yi Xue, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Comparative In Silico Structural Analysis of PHA Synthases from industrially Prominent PHA Producers
Orkun Pinar
Catalysis Letters (2025) Vol. 155, Iss. 4
Open Access
Binding affinities analysis of ivermectin, nucleocapsid and ORF6 proteins of SARS-CoV-2 to human importins α isoforms: A computational approach
E. Gayozo, Laura Rojas, Julio César Quiroz Barrios
BIOtecnia (2025) Vol. 27, pp. e2485-e2485
Closed Access
Nanotechnology and COVID-19: Prevention, diagnosis, vaccine, and treatment strategies
Sümeyra Ayan, Kubra Aranci-Ciftci, Fatih Çiftçi, et al.
Frontiers in Materials (2023) Vol. 9
Open Access | Times Cited: 10
Overview of Nucleocapsid-Targeting Vaccines against COVID-19
Alexandra Rak, Irina Isakova-Sivak, Larisa Rudenko
Vaccines (2023) Vol. 11, Iss. 12, pp. 1810-1810
Open Access | Times Cited: 10
Comparative analysis of aptamers binding to SARS-CoV-2 N protein using capillary electrophoresis and bio-layer interferometry
Gurcharan K. Uppal, Suttinee Poolsup, Emil Zaripov, et al.
Analytical and Bioanalytical Chemistry (2024) Vol. 416, Iss. 7, pp. 1697-1705
Closed Access | Times Cited: 3
Genome-wide identification, molecular evolution and gene expression of P450 gene family in Cyrtotrachelus buqueti
Chun Fu, Yang Ding, Wen Cong Long, et al.
BMC Genomics (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 3
Oncogenic potential of SARS-CoV-2—targeting hallmarks of cancer pathways
Aishwarya Jaiswal, Sanah Shrivastav, Hemant R. Kushwaha, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Newly Emerged Antiviral Strategies for SARS-CoV-2: From Deciphering Viral Protein Structural Function to the Development of Vaccines, Antibodies, and Small Molecules
Chunye Zhang, Ming Yang
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6083-6083
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top